Enhancement of Flow Properties, Solubility, and Dissolution of the Darunavir Ethanolate by Spherical Crystallization
Abstract
Crystal engineering is a field focused on designing and developing molecular solid particles with desired properties and functionalities. The crystal habit and polymorphic form of a substance play a crucial role in determining its physicochemical, mechanical, and biological behavior. Modifying the crystal habit alone can lead to the formation of distinct morphological forms, which directly influence particle orientation. Such alterations significantly affect critical parameters including flowability, packing density, compressibility, syringebility, and dissolution behavior of pharmaceutical powders. Particle size enlargement is typically accomplished through established conventional techniques, which are widely adopted in pharmaceutical manufacturing. The main objective of this study was to formulate sphere shaped crystal agglomerates of Darunavir Ethanolate (DRVE) having enhanced flowability, compression ability, solublisation property and dissolution. DVRE spherical crystals were developed by using 22 full factorial design approach. Plasdone 630 as polymer and methylene dichloride (MDC) as bridging solvent were considered as independent variables and their effect was studied on drug content and solubility considering as a dependent variable. The optimised spherical crystals were used in tablet formulations. The drug content of the spherical agglomerates ranged between 89.80 (SAD6) to 95% (SAD2). The solubility of the spherical agglomerates was ranged between 0.20 (SA6) to 1.80 mg/ml (SAD2) with 11.25-fold enhancement in solubility. FTIR study indicated the excellent compatibility of the drug with polymer used in formulation. XRD study suggested the amorphization of pure DVRE during the agglomeration process. The optimised SA2 spherical agglomerates were used to manufacture immediate release tablets by DC method (F1). Presence of spherical agglomerates has significantly improved the flow properties as well as compressibility of the blend in comparison pure DVRE. The drug release of F1 batch was found to be faster in comparison to F2 and F3 formulations. Nearly 100% release was observed within 15 minutes from F1. The study concludes that the use of spherical agglomerates leads to enhanced flow properties, compressibility, solubility, and dissolution behavior.
Keywords:
Darunavir Ethanolate, spherical crystallisation, solubility, dissolution, flow properties, compressibilityDOI
https://doi.org/10.25004/IJPSDR.2025.170402References
Sun WJ, Aburub A, Sun CC. Particle engineering for enabling a formulation platform suitable for manufacturing low-dose tablets by direct compression. Journal of pharmaceutical sciences. 2017;1;106(7):1772-1777. Available from: doi.org/10.1016/j.xphs.2017.03.005.
Cai L, Farber L, Zhang D, Li F, Farabaugh J. A new methodology for high drug loading wet granulation formulation development. International journal of pharmaceutics. 2013; 30;441(1-2):790-800. Available form: doi.org/10.1016/j.ijpharm.2012.09.052.
Lokeshvar R, Ramaiyan V, Nithin V, Pavani S, Vinod Kumar T. Nanotechnology-driven therapeutics for liver cancer: Clinical applications and pharmaceutical insights. Asian Journal of Pharmaceutical and Clinical Reseacrh. 2025;18(2):8-26. Available form: https://doi.org/10.22159/ajpcr.2025v18i2.53429
Kumar R, Thakur AK, Chaudhari P, Banerjee N. Particle size reduction techniques of pharmaceutical compounds for the enhancement of their dissolution rate and bioavailability. Journal of Pharmaceutical Innovation. 2022;17(2):333-352. Available from: doi.org/10.1007/s12247-020-09530-5
Hou H, Sun CC. Quantifying effects of particulate properties on powder flow properties using a ring shear tester. Journal of pharmaceutical sciences. 2008;1;97(9):4030-4039.Available from: doi.org/10.1002/jps.21288
Chauhan V, Mardia R, Patel M, Suhagia B, Parmar K. Technical and Formulation Aspects of Pharmaceutical Co‐Crystallization: A Systematic Review. ChemistrySelect. 2022; 7;7(37):e202202588. Available from: doi.org/10.1002/slct.202202588
Pindelska E, Sokal A, Kolodziejski W. Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques. Advanced drug delivery reviews. 2017;1; 117:111-146.Avaialable from: doi.org/10.1016/j.addr.2017.07.009
Mahajan NM, Malghade AD, Dumore NG, Thenge RR. Design and development of crystallo-co-agglomerates of Ritonavir for the improvement of physicochemical properties. Turkish Journal of Pharmaceutical Sciences. 2018;15(3):248. Available from: doi.org/10.4274/tjps.44227
Paradkar AR, Pawar AP. Crystallo-co-agglomeration: A novel particle engineering technique. Asian Journal of Pharmaceutics (AJP). 2010;4(1). Available from: doi.org/10.4103/0973-8398.63975
Bharti N, Bhandari N, Sharma P, Singh K, Kumar A. Spherical crystallization: a novel drug delivery approach. Asian journal of biomedical and pharmaceutical sciences. 2013; 1;3(18):10. Available from: doi.org/10.15272/ajbps.v3i18.166
Gupta MM, Srivastava B, Sharma M, Arya V. Spherical crystallization: A tool of particle engineering for making drug powder suitable for direct compression. International Journal of Pharmaceutical Research and Development. 2010; 1:1-10.
Thakur A, Thipparaboina R, Kumar D, Gouthami KS, Shastri NR. Crystal engineered albendazole with improved dissolution and material attributes. CrystEngComm. 2016;18(9):1489-1494. Available from: doi.org/10.1039/C5CE02476F
Chen H, Guo Y, Wang C, Dun J, Sun CC. Spherical cocrystallization—an enabling technology for the development of high dose direct compression tablets of poorly soluble drugs. Crystal Growth & Design. 2019 ;28;19(4):2503-2510. Available from: doi.org/10.1021/acs.cgd.8b01791
Lamešić D, Planinšek O, Lavrič Z, Ilić I. Spherical agglomerates of lactose with enhanced mechanical properties. International journal of pharmaceutics. 2017 Jan 10;516(1-2):247-257.Available from: doi.org/10.1016/j.ijpharm.2016.11.038
Chen H, Aburub A, Sun CC. Direct compression tablet containing 99% active ingredient—A tale of spherical crystallization. Journal of pharmaceutical sciences. 2019;1;108(4):1396-400. Available from: doi.org/10.1016/j.xphs.2018.11.010
Fadke J, Desai J, Thakkar H. Formulation development of spherical crystal agglomerates of itraconazole for preparation of directly compressible tablets with enhanced bioavailability. AAPS PharmSciTech. 2015; 16:1434-1444. Available from: doi.org/10.1208/s12249-015-0306-3
Jadhav AT, Pekamwar SS. Enhancement of flow properties, solubility, and dissolution of the atazanavir by spherical crystallization. Journal of Applied Pharmaceutical Research. 2025 Feb 28;13(1):191-204. Available from: doi.org/10.69857/joapr.v13i1.779
Hu X, Zhao Y, Xiao W, He G, Jiang H, Ruan X, Jiang X. Improved spherical particle preparation of ceftriaxone sodium via membrane-assisted spherical crystallization. Industrial & Engineering Chemistry Research. 2023;62(10):4444-4454.Available from: doi.org/10.1021/acs.iecr.2c04424
Zolotov SA, Demina NB, Zolotova AS, Shevlyagina NV, Buzanov GA, Retivov VM, Kozhukhova EI, Zakhoda OY, Dain IA, Filatov AR, Cheremisin AM. Development of novel darunavir amorphous solid dispersions with mesoporous carriers. European Journal of Pharmaceutical Sciences. 2021;1;159:105700. Available from: doi.org/10.1016/j.ejps.2021.105700
U.S. Food and Drug Administration. Prezista (darunavir) Prescribing Information. 2008. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021976s003s004lbl.pdf
Prashant R, Rakesh M, Tanaji N, Sushilkumar P. Solubility and dissolution enhancement of albendazole by spherical crystallization. Asian journal of biomedical and pharmaceutical sciences. 2016 ;1;6(52):09. Available from: doi.org/10.15272/ajbps.v6i52.807
Nandgude TD, Bhise KS, Gupta VB. Characterization of hydrochloride and tannate salts of diphenhydramine. Indian journal of pharmaceutical sciences. 2008;70(4):482. Available from: doi.org/10.4103/0250-474X.44600
Gohel MC, Parikh RK, Shah H, Dubey RR. Improvement in flowability and compressibility of ampicillin trihydrate by spherical crystallization. Indian journal of pharmaceutical sciences. 2003;65(6):634-637.
Reddy KT Kumar, Dharmamoorthy G, Vasavi Devi D, Vidiyala N, Bagade OM, Elumalai S, Sagar Dantinapalli VL, Kasimedu S. Phytoconstituent Based Green Synthesis of Nanoparticles: Sources and Biomedical Applications in Cancer Therapy. Asian Journal of Green Chemistry. 2025;9(3):329-354. Available from: Doi: 10.48309/AJGC.2025.501113.1669
Pharmacopoeia I. The Indian pharmacopoeia commission. Central Indian Pharmacopoeia Laboratory, Ministry of Health and Family Welfare, Govt of India, Sector. 2007;23.
Blagden N, de Matas M, Gavan PT, York P. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Advanced drug delivery reviews. 2007 30;59(7):617-630. Available from: doi.org/10.1016/j.addr.2007.05.011
Lee T, Chen JW, Lee HL, Lin TY, Tsai YC, Cheng SL, Lee SW, Hu JC, Chen LT. Stabilization and spheroidization of ammonium nitrate: Co-crystallization with crown ethers and spherical crystallization by solvent screening. Chemical Engineering Journal. 2013;1;225:809-817.Available from:doi.org/10.1016/j.cej.2013.04.002
Keshwani B, Jaimini M, Sharma DI. Spherical crystallisation: a revolution in the field of particle engineering. International Journal of Current Pharmaceutical Research. 2015;7(4):19-25.
Irigoiti Y, Yamul DK, Navarro AS. Co-crystallized sucrose with propolis extract as a food ingredient: Powder characterization and antioxidant stability. LWT-Food Science and Technology. 2021;1; 143:111164. Available from: doi.org/10.1016/j.lwt.2021.111164
Lamešić D, Grilc B, Roškar R, Kolokytha S, Hofmann J, Malekos A, Kaufmann R, Planinšek O. Spherical Agglomerates of Lactose Reduce Segregation in Powder Blends and Improve Uniformity of Tablet Content at High Drug Loads. AAPS PharmSciTech. 2021; 10;23(1):17. Available from: doi.org/10.1208/s12249-021-02150-3.
Dhondale MR, Nambiar AG, Singh M, Mali AR, Agrawal AK, Shastri NR, Kumar P, Kumar D. Current trends in API co-processing: spherical crystallization and co-precipitation techniques. Journal of Pharmaceutical Sciences. 2023;1;112(8):2010-2028.Availale from: doi.org/10.1016/j.xphs.2023.02.005.
Warren DB, Benameur H, Porter CJ, Pouton CW. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility. Journal of drug targeting. 2010;1;18(10):704-731.Available from: doi.org/10.3109/1061186X.2010.525652
Kedia K, Wairkar S. Improved micromeritics, packing properties and compressibility of high dose drug, Cycloserine, by spherical crystallization. Powder Technology. 2019;15;344:665-672. Available from: doi.org/10.1016/j.powtec.2018.12.068
Ahmed S, Islam S, Ullah B, Biswas SK, Azad AS, Hossain S. A Review Article on Pharmaceutical Analysis of Pharmaceutical Industry According to Pharmacopoeias. Oriental Journal of Chemistry. 2020;1;36(1). Available from: doi.org/10.13005/ojc/360101
Published
Abstract Display: 209 
PDF Downloads: 236 How to Cite
Issue
Section
Copyright (c) 2025 Sanjay S. Pekamwar, Ashok T. Jadhav
This work is licensed under a Creative Commons Attribution 4.0 International License.
